Skip to content
Nonprofiteer
← GATES MEDICAL RESEARCH INSTITUTE

Form 990 for tax year 2022

Filed by GATES MEDICAL RESEARCH INSTITUTE.

Totals

Total revenue
$12,321,803
Total expenses
$137,217,184
Contributions and grants received
$12,245,754
Grants paid
$0
Program service revenue
$0
Investment income
$58,534
Other revenue
$17,515
Total assets, end of year
$186,459,426
Total liabilities, end of year
$51,302,471
Net assets or fund balances, end of year
$135,156,955
Program services expenses (Part IX)
$121,145,471
Management and general expenses
$16,071,713
Fundraising expenses
$0
Program service expenses (Part III)
$121,145,471

Program services were 88.3% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1d · Related organizations

    $11,408,165

  • 1f · All other contributions, gifts and grants

    $837,589

  • 3 · Investment income

    total $58,534 · excluded $58,534

  • 11a · Other revenue: CURRENCY CONVERSION

    total $17,515 · excluded $17,515

  • 11e · Other revenue, total

    $17,515

Functional expenses

Part IX, the statement of functional expenses.

  • 5 · Compensation of officers, directors and key employees

    total $4,001,901 · program services $1,963,594 · management and general $2,038,307

  • 6 · Compensation of disqualified persons

    total $97,106 · management and general $97,106

  • 7 · Other salaries and wages

    total $28,758,306 · program services $24,891,234 · management and general $3,867,072

  • 8 · Pension plan contributions

    total $3,901,472 · program services $3,389,396 · management and general $512,076

  • 9 · Other employee benefits

    total $5,223,006 · program services $4,035,348 · management and general $1,187,658

  • 10 · Payroll taxes

    total $1,791,227 · program services $1,527,799 · management and general $263,428

  • 11b · Fees: legal

    total $779,842 · program services $649,731 · management and general $130,111

  • 11c · Fees: accounting

    total $200,750 · management and general $200,750

  • 11g · Fees: other

    total $74,947,617 · program services $70,986,924 · management and general $3,960,693

  • 13 · Office expenses

    total $652,655 · program services $515,727 · management and general $136,928

  • 14 · Information technology

    total $3,111,989 · program services $2,362,810 · management and general $749,179

  • 15 · Royalties

    total $3,500,000 · program services $3,500,000

  • 16 · Occupancy

    total $5,508,062 · program services $4,747,217 · management and general $760,845

  • 17 · Travel

    total $1,259,601 · program services $1,125,827 · management and general $133,774

  • 19 · Conferences, conventions and meetings

    total $66,654 · program services $64,653 · management and general $2,001

  • 22 · Depreciation, depletion and amortization

    total $1,814,132 · management and general $1,814,132

  • 23 · Insurance

    total $192,562 · program services $181,554 · management and general $11,008

  • 24a · Other expenses: RECRUITING

    total $777,500 · program services $666,250 · management and general $111,250

  • 24b · Other expenses: FURNITURE AND EQUIPMENT

    total $333,275 · program services $269,830 · management and general $63,445

  • 24c · Other expenses: DUES AND SUBSCRIPTION

    total $197,496 · program services $166,098 · management and general $31,398

  • 24d · Other expenses: OTHER TAXES AND FEES

    total $102,031 · program services $101,479 · management and general $552

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    end of year $0

  • 2 · Savings and temporary cash investments

    beginning of year $35,259,489 · end of year $50,468,880

  • 3 · Pledges and grants receivable

    beginning of year $222,963,535 · end of year $94,008,356

  • 4 · Accounts receivable

    beginning of year $46,821 · end of year $15,753

  • 9 · Prepaid expenses and deferred charges

    beginning of year $4,820,096 · end of year $4,484,872

  • 10a · Land, buildings and equipment: cost or other basis

    $44,354,196

  • 10b · Land, buildings and equipment: accumulated depreciation

    $7,566,160

  • 10c · Land, buildings and equipment, net

    beginning of year $13,832,666 · end of year $36,788,036

  • 15 · Other assets

    beginning of year $725,118 · end of year $693,529

  • 17 · Accounts payable and accrued expenses

    beginning of year $17,580,390 · end of year $51,302,471

  • 27 · Net assets without donor restrictions

    beginning of year $260,067,335 · end of year $135,156,955

  • 28 · Net assets with donor restrictions

    beginning of year $0 · end of year $0

Mission and programs · 2022

Mission

THE GATES MRI ENGAGES DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ONE OR MORE HOSPITALS FOR THE PURPOSE OF ADDRESSING MAJOR CAUSES OF ILLNESS AND DEATH IN LOW-AND LOWER-MIDDLE-INCOME COUNTRIES.

  • BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE ("GATES MRI") IS ALIGNED WITH THE PURPOSE OF THE BILL & MELINDA GATES FOUNDATION AND GUIDED BY THE VISION THAT EVERY PERSON DESERVES THE OPPORTUNITY TO LEAD A HEALTHY AND PRODUCTIVE LIFE. THE GATES MRI IS DEDICATED TO THE RESEARCH, DEVELOPMENT, AND EFFECTIVE USE OF NOVEL BIOMEDICAL INTERVENTIONS ADDRESSING SUBSTANTIAL GLOBAL HEALTH CONCERNS FOR WHICH THE REQUIRED DEVELOPMENT INVESTMENT BY TRADITIONAL BIOPHARMACEUTICAL ORGANIZATIONS IS LACKING. THE GATES MRI WORKS WITH COLLABORATING PARTNERS AND ORGANIZATIONS, COORDINATING AND DRIVING BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT ACTIVITIES, INCLUDING PRE-CLINICAL DEVELOPMENT AND CLINICAL DEVELOPMENT. IN ADDITION TO THE TUBERCULOSIS WORK NOTED IN 4(B) THE MRI FOCUSES ON PROGRAMS AIMED AT REDUCING THE BURDEN OF MALARIA, DIARRHEAL DISEASES, AND MATERNAL, NEWBORN, AND CHILD ILLNESSES WORLDWIDE.

    Expenses $68,753,923

  • THE GATES MRI'S LARGEST PROGRAM AREA FOCUSES ON REDUCING THE BURDEN OF TUBERCULOSIS THROUGH THE RESEARCH AND DEVELOPMENT OF NOVEL THERAPEUTICS AND VACCINE CANDIDATES, INCLUDING THROUGH THE CONDUCT OF CLINICAL TRIALS.

    Expenses $52,391,548

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • TREVOR MUNDEL

    DIRECTOR, BOARD CHAIR

    Total calculated
    $1,321,883
    From this org
    $0
    From related orgs
    $1,249,224
    Other
    $72,659
    Hours/week
    3 + 40 related

    Schedule J breakdown matched by us

    Base
    $0 + $1,188,822 related
    Bonus
    $0
    Other
    $0 + $60,402 related
    Deferred
    $0 + $45,750 related
    Nontaxable benefits
    $0 + $26,909 related
    Filer's total
    $0 + $1,321,883 related

  • CAROLYN AINSLIE

    DIRECTOR

    Total calculated
    $953,833
    From this org
    $0
    From related orgs
    $879,108
    Other
    $74,725
    Hours/week
    2 + 40 related

    Schedule J breakdown matched by us

    Base
    $0 + $825,032 related
    Bonus
    $0 + $132 related
    Other
    $0 + $53,944 related
    Deferred
    $0 + $45,750 related
    Nontaxable benefits
    $0 + $28,975 related
    Filer's total
    $0 + $953,833 related

  • TONI HOOVER

    DIRECTOR

    Total calculated
    $645,443
    From this org
    $0
    From related orgs
    $572,338
    Other
    $73,105
    Hours/week
    2 + 40 related

    Schedule J breakdown matched by us

    Base
    $0 + $542,925 related
    Bonus
    $0
    Other
    $0 + $29,413 related
    Deferred
    $0 + $45,750 related
    Nontaxable benefits
    $0 + $27,355 related
    Filer's total
    $0 + $645,443 related

  • HELENE MADONICK

    DIRECTOR

    Total calculated
    $32,038
    From this org
    $0
    From related orgs
    $32,038
    Other
    $0
    Hours/week
    2

  • SUSAN DESMOND-HELLMANN

    DIRECTOR (END 12/31/22)

    Total calculated
    $0
    Hours/week
    2

  • EMILIO EMINI

    CHIEF EXECUTIVE OFFICER

    Total calculated
    $849,038
    From this org
    $778,982
    From related orgs
    $0
    Other
    $70,056
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $746,668
    Bonus
    $0
    Other
    $32,314
    Deferred
    $45,750
    Nontaxable benefits
    $24,306
    Filer's total
    $849,038

  • MAHENDRA PATTNI

    TREASURER

    Total calculated
    $532,330
    From this org
    $448,355
    From related orgs
    $0
    Other
    $83,975
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $422,292
    Bonus
    $0
    Other
    $26,063
    Deferred
    $45,750
    Nontaxable benefits
    $38,225
    Filer's total
    $532,330

  • SALLY JENNINGS

    SECRETARY

    Total calculated
    $500,614
    From this org
    $416,831
    From related orgs
    $0
    Other
    $83,783
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $403,056
    Bonus
    $0
    Other
    $13,775
    Deferred
    $45,750
    Nontaxable benefits
    $38,033
    Filer's total
    $500,614

  • MICHAEL DUNNE

    CHIEF MEDICAL OFFICER, HEAD OF DEV.

    Total calculated
    $813,516
    From this org
    $725,742
    From related orgs
    $0
    Other
    $87,774
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $686,139
    Bonus
    $10,000
    Other
    $29,603
    Deferred
    $45,750
    Nontaxable benefits
    $42,024
    Filer's total
    $813,516

  • DEBRA WEISS

    CHIEF OPERATING OFFICER

    Total calculated
    $656,938
    From this org
    $585,274
    From related orgs
    $0
    Other
    $71,664
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $546,527
    Bonus
    $10,000
    Other
    $28,747
    Deferred
    $45,750
    Nontaxable benefits
    $25,914
    Filer's total
    $656,938

  • PIPER TRELSTADSTART 1322

    HEAD OF CHEM, MFG, CONTROL

    Total calculated
    $649,464
    From this org
    $565,246
    From related orgs
    $0
    Other
    $84,218
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $461,376
    Bonus
    $71,500
    Other
    $32,370
    Deferred
    $45,750
    Nontaxable benefits
    $38,468
    Filer's total
    $649,464

  • LEE BANSIL

    HEAD OF GLOBAL STRATEGIC COMMUNICATIONS

    Total calculated
    $622,403
    From this org
    $538,738
    From related orgs
    $0
    Other
    $83,665
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $384,292
    Bonus
    $37,680
    Other
    $116,766
    Deferred
    $45,750
    Nontaxable benefits
    $37,915
    Filer's total
    $622,403

  • CHARLES WELLS

    HEAD OF THERAPEUTICS DEVELOPMENT

    Total calculated
    $556,991
    From this org
    $485,103
    From related orgs
    $0
    Other
    $71,888
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $444,719
    Bonus
    $10,173
    Other
    $30,211
    Deferred
    $45,750
    Nontaxable benefits
    $26,138
    Filer's total
    $556,991

  • ALEXANDER SCHMIDT

    HEAD OF VACCINE DEVELOPMENT

    Total calculated
    $556,228
    From this org
    $471,658
    From related orgs
    $0
    Other
    $84,570
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $425,572
    Bonus
    $10,346
    Other
    $35,740
    Deferred
    $45,750
    Nontaxable benefits
    $38,820
    Filer's total
    $556,228

  • ANTONIO GONZALEZ LOPEZ

    CLINICAL DEVELOPMENT LEADER

    Total calculated
    $549,419
    From this org
    $477,427
    From related orgs
    $0
    Other
    $71,992
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $399,519
    Bonus
    $0
    Other
    $77,908
    Deferred
    $45,750
    Nontaxable benefits
    $26,242
    Filer's total
    $549,419

  • JANIE PARRINO

    CLINICAL DEVELOPMENT LEADER

    Total calculated
    $520,376
    From this org
    $461,406
    From related orgs
    $0
    Other
    $58,970
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $370,974
    Bonus
    $81,500
    Other
    $8,932
    Deferred
    $45,750
    Nontaxable benefits
    $13,220
    Filer's total
    $520,376

  • MARY THISTLE END 42922

    FORMER TREASURER, CHIEF OF STAFF

    Total calculated
    $97,106
    From this org
    $78,357
    From related orgs
    $0
    Other
    $18,749
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $73,564
    Bonus
    $0
    Other
    $4,793
    Deferred
    $11,035
    Nontaxable benefits
    $7,714
    Filer's total
    $97,106

  • JARED SILVERMANEND 123121

    HEAD OF TRANSLATIONAL DISCOVERY

    Total calculated
    $574,650
    From this org
    $487,966
    From related orgs
    $0
    Other
    $86,684
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $474,631
    Bonus
    $0
    Other
    $13,335
    Deferred
    $45,750
    Nontaxable benefits
    $40,934
    Filer's total
    $574,650

  • TARYN ROGALSKI-SALTER

    HEAD OF GLOBAL REG STRAT(END 1/3/22)

    Total calculated
    $540,326
    From this org
    $465,694
    From related orgs
    $0
    Other
    $74,632
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $427,222
    Bonus
    $0
    Other
    $38,472
    Deferred
    $45,750
    Nontaxable benefits
    $28,882
    Filer's total
    $540,326

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 1a · First-class or charter travel
  • 1a · Tax indemnification and gross-up payments
  • 1b · Written policy on the line-1a expenses
  • 2 · Substantiation required before reimbursing expenses
  • 3 · Independent compensation consultant
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 1A
THE TRAVEL POLICY, APPLICABLE TO ALL EMPLOYEES, ALLOWS FOR FIRST-CLASS AIR TRAVEL ON DOMESTIC RED-EYE FLIGHTS DEPARTING AFTER 9:00 PM THAT EXCEED FIVE HOURS IN DURATION. RELOCATION PACKAGES ARE GENERALLY PROVIDED TO NEW EMPLOYEES WHO RESIDE MORE THAN 50 MILES OUTSIDE OF CAMBRIDGE, MASSACHUSSETTS. THE ORGANIZATION GROSSES UP TAXABLE RELOCATION BENEFITS AND NOMINAL SPOT AWARDS FOR EXEMPLARY PERFORMANCE.
PART I, LINE 7
ALL EMPLOYEES ARE ELIGIBLE TO RECEIVE HIGH IMPACT BONUSES, ANNUALLY. THESE BONUSES ARE DISCRETIONARY TO BE PAID BASED ON PREDETERMINED FIXED AMOUNTS (BETWEEN $2,500 AND $10,000) AND THE TOTAL AMOUNT PAID IS DETERMINED BASED ON PERFORMANCE AND THE IMPACT ON THE ORGANIZATION. DURING 2022, GATES MEDICAL RESEARCH INSTITUTE PAID OUT HIGH IMPACT BONUSES, INCLUDING TO INDIVIDUALS LISTED ON PART VII, SECTION A.
PART VII, SECTION A, LINE 1:
TOTAL ANNUAL COMPENSATION IS REPORTED FOR ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES REGARDLESS OF THE LENGTH OF TIME ACTIVELY SERVING AS A DIRECTOR, OFFICER, OR KEY EMPLOYEE OF GATES MEDICAL RESEARCH INSTITUTE DURING 2022.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related partnerships

Part III: related organizations taxable as a partnership, with the filer's share.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

Provenance

Return type
form_990
Tax year
2022
Filed
3 November 2023
IRS schema version
2022v5.0
Source object
202343159349300224

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.